The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma
暂无分享,去创建一个
W. Hiddemann | A. Pastore | M. Dreyling | O. Weigert | M. Rieken | Y. Zimmermann | Marc Weinkauf | G. Hutter | M. Weinkauf